We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Immupharma Plc | LSE:IMM | London | Ordinary Share | GB0033711010 | ORD 1P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.23 | -9.24% | 2.26 | 2.21 | 2.31 | 2.38 | 2.35 | 2.38 | 403,787 | 16:35:14 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Finance Services | 0 | -3.81M | -0.0114 | -2.06 | 7.83M |
From Apr 2019 to Apr 2024
TIDMIMM
RNS Number : 4022Q
Immupharma PLC
06 June 2018
6 June 2018
This announcement contains inside information for the purposes of Article 7 of Regulation (EU) 596/2014.
ANNUAL REPORT AND ACCOUNTS POSTED TO SHAREHOLDERS
NOTICE OF ANNUAL GENERAL MEETING ON 28 JUNE 2018 @ 10.30 AM
VENUE: SKY LIGHT CITY TOWER, 50 BASINGHALL STREET, LONDON, EC2
ImmuPharma PLC (LSE:IMM), ("ImmuPharma" or the "Company"), the specialist drug discovery and development company confirms that the Annual Report and Accounts for the year ended 31 December 2017 has been posted to shareholders.
This report includes the 'Annual Report of the Annual General Meeting' ('AGM') as well as the 'Notice of the 2018 AGM', which will be available later today, in electronic form, for download on the Company's website www.immupharma.org.
ImmuPharma's AGM will be held on Thursday 28 June at 10:30am at Sky Light City Tower, 50 Basinghall Street, EC2V 5DE.
-Ends-
Hot Features
Premium
For further information please contact:
+ 44 (0) 20
ImmuPharma plc (www.immupharma.co.uk) 7152 4080
Tim McCarthy, Chairman
Lisa Baderoon, Head of Investor Relations + 44 (0) 7721
Twitter: @immupharma 413496
Northland Capital Partners Limited (NOMAD &
Joint Broker)
David Hignell, Dugald Carlean, Jamie Spotswood,
Corporate Finance +44 (0)20 3861
Rob Rees, Corporate Broking 6625
Bryan, Garnier & Co. (Joint Broker) +44 (0)20 7332 2500
Phil Walker, Corporate Finance
Dominic Wilson, Sales
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
END
NOALLFSERAIEIIT
(END) Dow Jones Newswires
June 06, 2018 02:01 ET (06:01 GMT)
1 Year Immupharma Chart |
1 Month Immupharma Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
